Veradigm Share Holder Equity 2012-2022 | MDRX
Veradigm share holder equity from 2012 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
|
Veradigm Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $804 |
| 2023 | $1,074 |
| 2022 | $1,018 |
| 2021 | $1,360 |
| 2020 | $1,666 |
| 2019 | $1,285 |
| 2018 | $1,580 |
| 2017 | $1,160 |
| 2016 | $1,273 |
| 2015 | $1,419 |
| 2014 | $1,284 |
| 2013 | $1,318 |
| 2012 | $1,284 |
| 2011 | $1,477 |
|
Veradigm Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2022-12-31 | $1,018 |
| 2022-09-30 | $1,177 |
| 2022-06-30 | $1,196 |
| 2022-03-31 | $1,353 |
| 2021-12-31 | $1,360 |
| 2021-09-30 | $1,419 |
| 2021-06-30 | $1,393 |
| 2021-03-31 | $1,679 |
| 2020-12-31 | $1,666 |
| 2020-09-30 | $1,208 |
| 2020-06-30 | $1,243 |
| 2020-03-31 | $1,242 |
| 2019-12-31 | $1,285 |
| 2019-09-30 | $1,281 |
| 2019-06-30 | $1,316 |
| 2019-03-31 | $1,456 |
| 2018-12-31 | $1,580 |
| 2018-09-30 | $1,117 |
| 2018-06-30 | $1,142 |
| 2018-03-31 | $1,110 |
| 2017-12-31 | $1,160 |
| 2017-09-30 | $1,147 |
| 2017-06-30 | $1,165 |
| 2017-03-31 | $1,189 |
| 2016-12-31 | $1,273 |
| 2016-09-30 | $1,370 |
| 2016-06-30 | $1,351 |
| 2016-03-31 | $1,389 |
| 2015-12-31 | $1,419 |
| 2015-09-30 | $1,396 |
| 2015-06-30 | $1,392 |
| 2015-03-31 | $1,278 |
| 2014-12-31 | $1,284 |
| 2014-09-30 | $1,283 |
| 2014-06-30 | $1,299 |
| 2014-03-31 | $1,308 |
| 2013-12-31 | $1,318 |
| 2013-09-30 | $1,331 |
| 2013-06-30 | $1,368 |
| 2013-03-31 | $1,334 |
| 2012-12-31 | $1,284 |
| 2012-09-30 | $1,299 |
| 2012-06-30 | $1,281 |
| 2012-03-31 | $1,490 |
| 2011-12-31 | $1,477 |
| 2011-09-30 | $1,439 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.594B | $0.594B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.168B | 43.07 |
| Tempus AI (TEM) | United States | $12.423B | 0.00 |
| 10x Genomics (TXG) | United States | $9.692B | 0.00 |
| Hinge Health (HNGE) | United States | $7.455B | 71.62 |
| Hims & Hers Health (HIMS) | United States | $6.498B | 0.00 |
| Doximity (DOCS) | United States | $4.601B | 28.36 |
| Heartflow (HTFL) | United States | $4.202B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.688B | 243.22 |
| Privia Health (PRVA) | United States | $2.601B | 96.95 |
| Clover Health Investments (CLOV) | United States | $2.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.157B | 32.86 |
| Butterfly Network (BFLY) | United States | $2.077B | 0.00 |
| Schrodinger (SDGR) | United States | $1.716B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 21.19 |
| Azenta (AZTA) | United States | $1.447B | 78.64 |
| Enovis (ENOV) | United States | $1.035B | 5.36 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.668B | 0.00 |
| Phreesia (PHR) | United States | $0.642B | 34.50 |
| Claritev (CTEV) | United States | $0.602B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.416B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.371B | 0.00 |
| CapsoVision (CV) | United States | $0.319B | 0.00 |
| Standard BioTools (LAB) | United States | $0.271B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 6.41 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.064B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.051B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |